Fexofenadine as Adjuvant Therapy in Parkinson Disease
Clinical trial NCT06785298 · RECRUITING
Trial details
- NCT number
- NCT06785298
- Sponsor
- Tanta University
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-10
- Primary completion
- 2026-12-10
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.